Literature DB >> 14585218

Replication kinetics for divergent type 1 human immunodeficiency viruses using quantitative SYBR green I real-time polymerase chain reaction.

Joseph G Victoria1, Deborah J Lee, Brenda R McDougall, W Edward Robinson.   

Abstract

A quantitative and sensitive measure of human immunodeficiency virus type 1 (HIV-1) replication is quantitative real-time polymerase chain reaction (PCR). Real-time PCR using SYBR green I and oligonucleotide primers that amplify early, intermediate, and late products of reverse transcription were optimized to measure HIV-1 replication of clade A, B, C, and D HIV-1 isolates in peripheral blood lymphocytes and in both transformed and viral-transformed CD4+ lymphocyte cell lines. Real-time PCR can detect HIV-1 replication as early as 1 hr postinfection and demonstrates that in established cell lines cDNA can be detected as early as 4 hr postinfection. The first round of HIV-1 replication in established cell lines is complete between 12 and 24 hr postinfection. Furthermore, real-time PCR can detect HIV-1 replication in fewer than 0.1% of cells. Patient isolates replicated at different rates in peripheral blood lymphocytes, with viral cDNA peaking between 48 and 120 hr, depending on the virus being studied. Real-time PCR differentiated the mechanisms of action of drugs targeted at HIV-1 entry, reverse transcription, and proteolytic processing and identified differences in the kinetics of reverse transcription between zidovudine-sensitive and zidovudine-resistant HIV in the presence of zidovudine. In summary, real-time PCR using SYBR green I dye is a sensitive, quantitative, and reproducible measure of replication kinetics for a variety of group M HIV-1 isolates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14585218     DOI: 10.1089/088922203322493030

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  11 in total

1.  Exploiting drug repositioning for discovery of a novel HIV combination therapy.

Authors:  Christine L Clouser; Steven E Patterson; Louis M Mansky
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

Review 2.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  A cell-based strategy to assess intrinsic inhibition efficiencies of HIV-1 reverse transcriptase inhibitors.

Authors:  Michael E Abram; Manuel Tsiang; Kirsten L White; Christian Callebaut; Michael D Miller
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

4.  Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Fernando A Frankel; Bruno Marchand; Dan Turner; Matthias Götte; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis.

Authors:  David C Thomas; Yegor A Voronin; Galina N Nikolenko; Jianbo Chen; Wei-Shau Hu; Vinay K Pathak
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 (HIV-1) integrase: resistance to diketo acid integrase inhibitors impairs HIV-1 replication and integration and confers cross-resistance to L-chicoric acid.

Authors:  Deborah J Lee; W E Robinson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Differential effects on human immunodeficiency virus type 1 replication by alpha-defensins with comparable bactericidal activities.

Authors:  Hiroki Tanabe; Andre J Ouellette; Melanie J Cocco; W Edward Robinson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Guanidine alkaloid analogs as inhibitors of HIV-1 Nef interactions with p53, actin, and p56lck.

Authors:  Allison Olszewski; Ken Sato; Zachary D Aron; Frederick Cohen; Aleishia Harris; Brenda R McDougall; W Edward Robinson; Larry E Overman; Gregory A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-15       Impact factor: 11.205

9.  Real-time PCR analysis of HIV-1 replication post-entry events.

Authors:  Jean L Mbisa; Krista A Delviks-Frankenberry; James A Thomas; Robert J Gorelick; Vinay K Pathak
Journal:  Methods Mol Biol       Date:  2009

10.  The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA.

Authors:  Cameron P Keating; Melissa K Hill; David J Hawkes; Redmond P Smyth; Catherine Isel; Shu-Yun Le; Ann C Palmenberg; John A Marshall; Roland Marquet; Gary J Nabel; Johnson Mak
Journal:  Nucleic Acids Res       Date:  2008-12-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.